Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AGGRASTAT® (tirofiban hydrochloride) safely and effectively. See full prescribing information for AGGRASTAT. AGGRASTAT (tirofiban hydrochloride) injection, for intravenous use Initial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
AGGRASTAT® is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
- generic_name
- tirofiban
- product_names
- TIROFIBAN
- ndc
- 25208-002, 25208-001, 25208-002-02, 25208-002-03, 25208-002-01, 25208-001-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en